Vertex Pharmaceuticals Inc., of Cambridge, Mass., and Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), a nonprofit drug discovery and development affiliate of the CF Foundation, will collaborate on the discovery and development of new medicines known as correctors that aim to treat the underlying cause of cystic fibrosis in people with the most common form of the disease.